A detailed history of Wealthquest Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealthquest Corp holds 5,256 shares of LLY stock, worth $4.19 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
5,256
Previous 5,191 1.25%
Holding current value
$4.19 Million
Previous $4.7 Million 0.92%
% of portfolio
0.52%
Previous 0.74%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$772.14 - $960.02 $50,189 - $62,401
65 Added 1.25%
5,256 $4.66 Million
Q2 2024

Aug 26, 2024

SELL
$724.87 - $909.04 $54,365 - $68,178
-75 Reduced 1.42%
5,191 $4.7 Million
Q4 2023

Feb 15, 2024

SELL
$525.19 - $619.13 $9,453 - $11,144
-18 Reduced 0.34%
5,266 $3.07 Million
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $185,182 - $255,301
426 Added 8.77%
5,284 $2.84 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $6,313 - $8,441
-18 Reduced 0.37%
4,858 $2.28 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $120,581 - $140,501
-375 Reduced 7.14%
4,876 $1.78 Million
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $5,336 - $6,081
18 Added 0.34%
5,251 $1.7 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $43,845 - $54,412
-195 Reduced 3.59%
5,233 $1.45 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $1,994 - $2,454
-9 Reduced 0.17%
5,428 $1.25 Million
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $1,150 - $1,489
-7 Reduced 0.13%
5,437 $1.02 Million
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $49,574 - $65,599
-380 Reduced 6.52%
5,444 $919,000
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $35,059 - $42,194
-257 Reduced 4.23%
5,824 $956,000
Q2 2019

Jul 22, 2019

SELL
$110.79 - $129.32 $25,038 - $29,226
-226 Reduced 3.58%
6,081 $673,000
Q1 2019

Apr 18, 2019

BUY
$111.31 - $131.02 $10,463 - $12,315
94 Added 1.51%
6,307 $818,000
Q4 2018

Jan 23, 2019

BUY
$105.9 - $118.64 $657,956 - $737,110
6,213 New
6,213 $719,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wealthquest Corp Portfolio

Follow Wealthquest Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthquest Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wealthquest Corp with notifications on news.